CSS
NUVB icon

Cubist Systematic Strategies’s Nuvation Bio NUVB Stock Holding History

Cubist Systematic Strategies’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67,002
Closed -$153K – 3372
2024
Q3 		$153K Buy
+67,002
New +$204K ﹤0.01% 2629
2024
Q2 		– Sell
-77,737
Closed -$283K – 3710
2024
Q1 		$283K Sell
77,737
-12,867
-14% -$24.7K ﹤0.01% 2902
2023
Q4 		$137K Buy
90,604
+74,855
+475% +$96.3K ﹤0.01% 3109
2023
Q3 		$21.1K Buy
+15,749
New +$26.2K ﹤0.01% 3091
2023
Q2 		– Sell
-35,446
Closed -$58.8K – 4051
2023
Q1 		$58.8K Sell
35,446
-9,006
-20% -$18.3K ﹤0.01% 3541
2022
Q4 		$85.3K Sell
44,452
-28,741
-39% -$58.2K ﹤0.01% 3832
2022
Q3 		$164K Sell
73,193
-237,843
-76% -$679K ﹤0.01% 3844
2022
Q2 		$1.01M Buy
311,036
+153,183
+97% +$668K 0.01% 2478
2022
Q1 		$830K Buy
157,853
+107,262
+212% +$603K 0.01% 2183
2021
Q4 		$430K Buy
50,591
+50,587
+1,264,675% +$465K ﹤0.01% 2556
2021
Q3 		$0 Sell
4
-30,882
-100% -$280K ﹤0.01% 3116
2021
Q2 		$288K Sell
30,886
-149,381
-83% -$1.7M ﹤0.01% 2358
2021
Q1 		$1.88M Buy
+180,267
New +$2.02M 0.02% 1077

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Cubist Systematic Strategies's NUVB Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 67,002 shares — an estimated $153K sold.

Cubist Systematic Strategies first reported a position in NUVB in Q1 2021 and held it in 13 quarters. The position peaked at $1.88M in Q1 2021. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 67,002 Nuvation Bio shares in Q4 2024, an estimated $153K.
  • Cubist Systematic Strategies first reported a position in Nuvation Bio in Q1 2021 and held it in 13 quarters.
  • Cubist Systematic Strategies's Nuvation Bio position peaked at $1.88M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.